Literature DB >> 9317147

Protective effects of IL-4, IL-10, IL-12, and IL-13 in IgG immune complex-induced lung injury: role of endogenous IL-12.

M S Mulligan1, R L Warner, J L Foreback, T P Shanley, P A Ward.   

Abstract

Using the IgG immune complex (BSA-anti-BSA) model of acute lung injury in rats, we have compared four intratracheally administered cytokines for their protective effects on parameters of injury (albumin leak and hemorrhage) and on neutrophil accumulation (lung content of myeloperoxidase). The descending rank order of protective effects was: IL-10 > or = IL-13 > IL-4 > > IL-12. In animals receiving an intratracheal instillation of 1.0 microg murine rIL-4, IL-10, IL-12 or IL-13, the levels of TNF-alpha in bronchoalveolar (BAL) fluids after intrapulmonary deposition of IgG immune complexes were reduced by 98, 98, 34, and 97%, respectively, implying a corresponding reduction in up-regulation of lung vascular intercellular adhesion molecule-1. The unexpected findings with IL-12 were further evaluated. In spite of reduced BAL levels of TNF-alpha in IL-12-treated animals, BAL levels of IFN-gamma were elevated sixfold, indicative of the expected biologic response to IL-12. Alveolar macrophages obtained from the same animals showed a 68% reduction in formation in vitro of NO2-/NO3-. When rats undergoing intrapulmonary deposition of IgG immune complexes were treated either i.v. or intratracheally with blocking Ab to murine IL-12, there were significant increases in lung permeability and myeloperoxidase values, suggesting that in this model intrinsic IL-12 functions in a regulatory manner. In homogenates of injured lungs, this Ab detected heterodimeric complex, consistent with rat IL-12. These data confirm the ability of certain cytokines to suppress in vivo lung inflammatory responses and underscore the unexpected anti-inflammatory activities of IL-12.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9317147

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  14 in total

1.  Hypoxia aggravates lipopolysaccharide-induced lung injury.

Authors:  D Vuichard; M T Ganter; R C Schimmer; D Suter; C Booy; L Reyes; T Pasch; B Beck-Schimmer
Journal:  Clin Exp Immunol       Date:  2005-08       Impact factor: 4.330

2.  Inhibition of gamma interferon decreases bacterial load in peritonitis by accelerating peritoneal fibrin deposition and tissue repair.

Authors:  Gang Qiu; Elizabeth Gribbin; Kathryn Harrison; Neil Sinha; Kingsley Yin
Journal:  Infect Immun       Date:  2003-05       Impact factor: 3.441

3.  Interleukin-13 protects mouse intestine from ischemia and reperfusion injury through regulation of innate and adaptive immunity.

Authors:  Douglas G Farmer; Bibo Ke; Xiu-Da Shen; Fady M Kaldas; Feng Gao; Melissa J Watson; Ronald W Busuttil; Jerzy W Kupiec-Weglinski
Journal:  Transplantation       Date:  2011-04-15       Impact factor: 4.939

4.  IL-10 inhibits inflammatory cytokines released by fetal mouse lung fibroblasts exposed to mechanical stretch.

Authors:  Renda L Hawwa; Michael A Hokenson; Yulian Wang; Zheping Huang; Surendra Sharma; Juan Sanchez-Esteban
Journal:  Pediatr Pulmonol       Date:  2011-02-18

5.  IL-13 activates STAT6 and inhibits liver injury induced by ischemia/reperfusion.

Authors:  H Yoshidome; A Kato; M Miyazaki; M J Edwards; A B Lentsch
Journal:  Am J Pathol       Date:  1999-10       Impact factor: 4.307

6.  Effects of the TLR2 agonists MALP-2 and Pam3Cys in isolated mouse lungs.

Authors:  Martina Barrenschee; Dennis Lex; Stefan Uhlig
Journal:  PLoS One       Date:  2010-11-16       Impact factor: 3.240

7.  Effect of IL-10 on neutrophil recruitment and survival after Pseudomonas aeruginosa challenge.

Authors:  Lei Sun; Ren-Feng Guo; Michael W Newstead; Theodore J Standiford; Demetrio R Macariola; Thomas P Shanley
Journal:  Am J Respir Cell Mol Biol       Date:  2008-12-18       Impact factor: 6.914

8.  In vivo suppression of NF-kappa B and preservation of I kappa B alpha by interleukin-10 and interleukin-13.

Authors:  A B Lentsch; T P Shanley; V Sarma; P A Ward
Journal:  J Clin Invest       Date:  1997-11-15       Impact factor: 14.808

Review 9.  Application of proteomics to neutrophil biology.

Authors:  Gregory C Luerman; Silvia M Uriarte; Madhavi J Rane; Kenneth R McLeish
Journal:  J Proteomics       Date:  2009-07-04       Impact factor: 4.044

10.  Inhibition of NF-kappaB activation and augmentation of IkappaBbeta by secretory leukocyte protease inhibitor during lung inflammation.

Authors:  A B Lentsch; J A Jordan; B J Czermak; K M Diehl; E M Younkin; V Sarma; P A Ward
Journal:  Am J Pathol       Date:  1999-01       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.